(IHME, University of Washington, 2020)
Anita Petruzzelli, a dual board-certified OB-GYN and integrative medicine physician, combines advanced medical science with personalized, patient-focused strategies to deliver comprehensive care
Tirzepatide is a GIP and GLP-1 agonist and is used to treat type 2 diabetes, in addition to diet and exercise
It works for injectable GLP-1s Wegovy, Zepbound, Ozempic, Mounjaro, semaglutide, tirzepatide, and compounded forms and for oral GLP-1s including Rybelsus, oral Wegovy, Foundayo, and orforglipron
No minimum effective dose or maximum tolerated dose has been established in human oral trials